EUVIMEDEUVIMED entdecken
Open Access

Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice

Belle Buzzi, Shakir D AlSharari, David M Walentiny, M Imad Damaj

Behavioural Brain Research · 2024

DOI: 10.1016/j.bbr.2024.115019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2024. Verfasst von Belle Buzzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: buzzib@vcu.edu. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Reward, Nicotine, Mice, Inbred ICR. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health, King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Withdrawal SyndromeRewardNicotineMice, Inbred ICRSerotonin 5-HT2 Receptor AgonistsAnimalsMaleMiceDose-Response Relationship, DrugTobacco Use DisorderHyperalgesiaReceptor, Serotonin, 5-HT2AAnxietyNicotinic Agonists

Stichwörter der Autor:innen

5-HT2A receptorConditioned place preferenceNelotanserinNicotineWithdrawal

Substanzen

NicotineSerotonin 5-HT2 Receptor AgonistsReceptor, Serotonin, 5-HT2ANicotinic Agonists

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: buzzib@vcu.edu.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.

Förderung

  • NIDA NIH HHS
  • National Institutes of Health
  • King Saud University
  • National Institute on Drug Abuse

Zitieren

APA

Buzzi, B., AlSharari, S. D., Walentiny, D. M., & Damaj, M. I. (2024). Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2024.115019

Vancouver

Buzzi B, AlSharari SD, Walentiny DM, Damaj MI. Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice. Behavioural Brain Research. 2024. doi:10.1016/j.bbr.2024.115019

BibTeX
@article{Buzzi2024,
  author = {Buzzi, Belle and AlSharari, Shakir D and Walentiny, David M and Damaj, M Imad},
  title = {Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice},
  journal = {Behavioural Brain Research},
  year = {2024},
  doi = {10.1016/j.bbr.2024.115019}
}
Kostenlos starten →